Pharmaceutical Technology

MARCH 27, 2023

Regenerative medicines in early-stage development (preclinical, discovery, or investigational new drug [IND]/ clinical trial application [CTA] filed status) have seen a change in drug targets compared to therapies in late-stage development (Phase II to pre-registration stage).

Medicine 246

Medicine Gene Therapy Gene Dermatology 246

Bio Pharma Dive

OCTOBER 30, 2023

The venture firm has supported a number of approved medicines with its co-development strategy, including Pfizer’s Besponsa and Apellis’ Empaveli.

Development 264

Development Medicine Drugs 264

Bio Pharma Dive

OCTOBER 24, 2023

Rampart Biosciences closed a Series A round that will fund its goal to develop more potent DNA-based medicines that avoid immune responses.

DNA 263

DNA Medicine Immune Response Development 263

Pharmaceutical Technology

APRIL 13, 2023

Clinical-stage biopharmaceutical firm Alentis Therapeutics has raised $105m in a Series C financing round for advancing transformational medicines targeting the CLAUDIN-1 protein. ALE.F02 is being developed for the treatment of advanced kidney, lung and liver fibrosis while ALE.C04 is a potential treatment to target CLDN1-positive tumours.

Medicine 130

Medicine Development Antibody Engineer 130

Pharmaceutical Technology

JANUARY 31, 2024

Regeneron Pharmaceuticals has formed Regeneron Cell Medicines, a new research & development (R&D) unit in oncology and immunology.

Medicine 130

Medicine Development Research 130

Bio Pharma Dive

MARCH 25, 2024

As precision medicine expands into a growing number of therapeutic areas, the “one size fits all” approach to drug development is becoming less common.

Development 148

Development Medicine Drugs 148

Bio Pharma Dive

JULY 12, 2023

Backed by F-Prime Capital and Sofinnova Partners, the company claims to have technology that could allow it replace eye cells destroyed in age-related and inherited ocular conditions.

Medicine 234

Medicine Development 234

Pharmaceutical Technology

SEPTEMBER 21, 2023

Kezar and Everest Medicines have signed a deal for the development and commercialisation of zetomipzomib for lupus nephritis.

Development 246

Development Medicine 246

Pharmaceutical Technology

JANUARY 2, 2024

PYC Therapeutics has announced plans to enter a collaboration with Google Cloud for the development of new precision medicines.

Medicine 147

Medicine Development 147

pharmaphorum

MARCH 27, 2024

Teva UK has joined forces with techbio company Closed Loop Medicine to develop digital companions for pharma products that could provide personalised medicine

Medicine 95

Medicine Pharma Production Production Development 95

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 11, 2023

The pharma companies’ thrust on R&D to develop better medicines and the demand in hospitals for advanced medical technologies driven by artificial intelligence, remote patient monitoring and wearables are transforming patient care.

Medicine 148

Medicine Development Pharma Companies Clinical Trials 148

Bio Pharma Dive

MARCH 16, 2022

Draft recommendations from the agency were generally straightforward, analysts said, although the document emphasized the potential safety risks of gene editing.

Gene Editing 319

Gene Editing Gene Medicine Development 319

Pharmaceutical Technology

MARCH 22, 2024

Mirador Therapeutics has announced its launch, securing more than $400m in funding to develop precision medicines.

Development 130

Development Medicine 130

Bio Pharma Dive

DECEMBER 10, 2023

A new sickle cell disease therapy developed by CRISPR Therapeutics and Vertex Pharmaceuticals is now approved in the U.S. This is the story of how it came to be.

Medicine 356

Medicine Development 356

pharmaphorum

APRIL 15, 2024

The advancement of medicine is dependent on secure pharmaceutical supply chains. Discover why ensuring the security of these chains is crucial for the development and distribution of life-saving medications.

Medicine 80

Medicine Development 80

Pharmaceutical Technology

JANUARY 4, 2024

(Amlodipine + indapamide + telmisartan) is under clinical development by George Medicines and currently in Phase III for Hypertension.

Medicine 130

Medicine Clinical Development Development 130

Pharmaceutical Technology

JUNE 1, 2023

A new intracellular drug delivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and therapeutics , as well as the development of innovative drug delivery technologies. The funding is being provided under the agency’s Transforming Medicines Manufacturing programme.

Drug Delivery 242

Drug Delivery RNA Development Drugs 242

pharmaphorum

OCTOBER 12, 2022

Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. The evolving field of genomic medicine.

Genome 98

Genome Genomics Medicine Development 98

Pharmaceutical Technology

FEBRUARY 15, 2024

Latigo Biotherapeutics has secured $135m in a Series A funding round to advance the development of its non-opioid pain medicines.

Development 130

Development Medicine Drugs 130

Pharmaceutical Technology

MAY 17, 2023

Chinook Therapeutics and Ionis Pharmaceuticals have entered a partnership to develop an antisense oligonucleotide (ASO) therapy to treat a rare, severe chronic kidney disease. The collaboration aims to discover, develop and commercialise an ASO therapy.

Development 246

Development Protein RNA Genetics 246

Pharmaceutical Technology

MARCH 20, 2023

RVAC Medicines has announced a research collaboration with the University of Pennsylvania (Penn) for the discovery and development of mRNA vaccines. The partnership will focus on developing potential new vaccines to treat certain selected autoimmune indications, as well as food allergies.

Vaccination 245

Vaccination Vaccine Development Allergies 245

BioSpace

JULY 13, 2023

Government Accountability Office finds that despite the promise of regenerative medicine technologies they are held back by regulatory and manufacturing challenges. A new report by the U.S.

Medicine 98

Medicine Development Manufacturing 98

Pharmaceutical Technology

FEBRUARY 8, 2024

Despite several ground-breaking developments, pharmaceutical and biotech companies are often reluctant to invest in cell and gene therapy.

Gene Therapy 246

Gene Therapy Gene Medicine Development 246

Rethinking Clinical Trials

APRIL 24, 2024

Matthew Semler In this Friday's PCT Grand Rounds, Lauren Milner of the US Food and Drug Administration (FDA) and Jonathan Casey and Matthew Semler of Vanderbilt University will present "Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations – FDA Regulation Development and Research Landscape."

Development 141

Development Research Clinical Trials Clinical Trials 141

Pharmaceutical Technology

DECEMBER 15, 2022

Eisai has entered a comprehensive research partnership agreement with Washington University School of Medicine in St Louis, US, to develop potential new therapies for neurodegenerative ailments. Under the deal, the parties intend to develop treatments for diseases including Alzheimer’s and Parkinson’s.

Development 246

Development Medicine Sales Scientist 246

pharmaphorum

JUNE 9, 2023

Developing bold medicines to preserve vision and transform the treatment landscape for DME Mike.Hammerton Fri, 09/06/2023 - 13:00 Bookmark this

Medicine 86

Medicine Development 86

Pharmaceutical Technology

APRIL 12, 2023

Cognizant and Boehringer Ingelheim are collaborating on an integrated cloud platform to enhance the speed and quality of medicinal therapy development. Cognizant will leverage the Veeva Development Cloud platform to help Boehringer Ingelheim to merge medicinal development processes and data into a connected technology ecosystem.

Medicine 130

Medicine Life Science Development Branding 130

BioPharma Reporter

MARCH 26, 2024

Teva UK and Closed Loop Medicine have announced a strategic partnership to advance the development of personalized medicine.

Medicine 52

Medicine Development Regulation Marketing 52

Pharmaceutical Technology

AUGUST 3, 2023

Ionis has signed a licence agreement with Novartis to advance a programme targeting lipoprotein(a) (Lp(a)) for cardiovascular disease (CVD).

Medicine 130

Medicine Development 130

Pharmaceutical Technology

APRIL 10, 2023

Aviceda Therapeutics (Aviceda) has entered into a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (QUB) for the development of next-generation glyco-immune therapeutics. Aviceda Glycotech has been created as an oncology-focused spin-off company from Aviceda Therapeutics and Queen’s.

Development 259

Development Life Science Clinical Trials Clinical Trials 259

Pharmaceutical Technology

MAY 4, 2023

Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration. This will improve accessibility to services for AAV-mediated gene therapy programmes. This will improve accessibility to services for AAV-mediated gene therapy programmes.

Gene Therapy 256

Gene Therapy Gene Development Manufacturing 256

Pharmaceutical Technology

NOVEMBER 21, 2022

RVAC Medicines has signed a master research partnership agreement with the Agency for Science, Technology and Research (A*STAR) for analysing and developing solutions to build messenger ribonucleic acid (mRNA) manufacturing and analytics expertise in Singapore. Topic sponsors are not involved in the creation of editorial content.

Manufacturing 130

Manufacturing Medicine Vaccination Vaccine 130

Bio Pharma Dive

AUGUST 1, 2023

The all-stock deal is a quiet end for the ambitious biotech, which was sold for its billion-dollar bank account after the FDA derailed its plans to develop low-cost cancer medicines.

Medicine 130

Medicine Drugs Development 130

Pharmaceutical Technology

OCTOBER 28, 2022

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Robots can improve drug discovery and development. Lab-specific industrial co-bots can carry out both complex and repetitive tasks such as liquid handling.

Development 311

Development Drugs Pharma Companies Life Science 311

Pharmaceutical Technology

JUNE 23, 2023

The regulatory framework governing medicine development is in flux. CDMOs face growing challenges to keep up with QA and compliance.

Compliance 130

Compliance Medicine Development 130

Pharmaceutical Technology

OCTOBER 26, 2023

Flashpoint Therapeutics has secured $10m in a seed funding round to develop nanotechnology-enabled medicines.

Development 130

Development Medicine 130

Pharmaceutical Technology

JUNE 20, 2023

The Department of Health Abu Dhabi (DoH) has signed a memorandum of understanding with integrated healthcare company M42 and AbbVie Biopharmaceuticals to advance personalised medicine and genomics in the city. M42 was created through the combination of Mubadala Health and G42 Healthcare.

Medicine 130

Medicine Genome Genomics Clinical Trials 130